A randomized comparison ofatrial and dual-chamber pacing in177 consecutive patients with sick sinus syndrome Echocardiographic and clinical outcome by Nielsen, Jens C et al.
A Randomized Comparison of
Atrial and Dual-Chamber Pacing in
177 Consecutive Patients With Sick Sinus Syndrome
Echocardiographic and Clinical Outcome
Jens C. Nielsen, MD, PHD,* Lene Kristensen, MD,* Henning R. Andersen, MD, DMSC,*
Peter T. Mortensen, MD,* Ole L. Pedersen, MD, DMSC,† Anders K. Pedersen, MD, DMSC*
Aarhus and Viborg, Denmark
OBJECTIVES A randomized trial was done to compare single-chamber atrial (AAI) and dual-chamber
(DDD) pacing in patients with sick sinus syndrome (SSS). Primary end points were changes
in left atrial (LA) size and left ventricular (LV) size and function as measured by M-mode
echocardiography.
BACKGROUND In patients with SSS and normal atrioventricular conduction, it is still not clear whether the
optimal pacing mode is AAI or DDD pacing.
METHODS A total of 177 consecutive patients (mean age 74  9 years, 73 men) were randomized to
treatment with one of three rate-adaptive (R) pacemakers: AAIR (n  54), DDDR with a
short atrioventricular delay (n  60) (DDDR-s), or DDDR with a fixed long atrioventricular
delay (n  63) (DDDR-l). Before pacemaker implantation and at each follow-up, M-mode
echocardiography was done to measure LA and LV diameters. Left ventricular fractional
shortening (LVFS) was calculated. Analysis was on an intention-to-treat basis.
RESULTS Mean follow-up was 2.9  1.1 years. In the AAIR group, no significant changes were
observed in LA or LV diameters or LVFS from baseline to last follow-up. In both DDDR
groups, LA diameter increased significantly (p  0.05), and in the DDDR-s group, LVFS
decreased significantly (p  0.01). Atrial fibrillation was significantly less common in the
AAIR group, 7.4% versus 23.3% in the DDDR-s group versus 17.5% in the DDDR-l group
(p  0.03, log-rank test). Mortality, thromboembolism, and congestive heart failure did not
differ between groups.
CONCLUSIONS During a mean follow-up of 2.9  1.1 years, DDDR pacing causes increased LA diameter,
and DDDR pacing with a short atrioventricular delay also causes decreased LVFS. No
changes occur in LA or LV diameters or LVFS during AAIR pacing. Atrial fibrillation is
significantly less common during AAIR pacing. (J Am Coll Cardiol 2003;42:614–23)
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In patients with sick sinus syndrome (SSS), normal atrio-
ventricular (AV) conduction, and no bundle branch block,
the bradycardia-related symptoms can be treated success-
fully with a single-chamber atrial pacemaker (AAI), a
single-chamber ventricular pacemaker (VVI), or a dual-
chamber pacemaker (DDD). In a previous randomized trial
See page 624
of 225 patients with SSS (1,2), AAI pacing was superior to
VVI pacing due to lower mortality, less atrial fibrillation
(AF), less arterial thromboembolism, and less heart failure
(HF). In that study, VVI pacing caused an increased
dilation of the left atrial (LA) diameter and a decreased left
ventricular (LV) fractional shortening (LVFS) as docu-
mented by serial M-mode echocardiograms. It is likely that
the atrial dilation and reduced LV function caused by right
ventricular (RV) pacing was associated with a worse clinical
outcome in the VVI group. It is, however, not known
whether the disturbance of AV synchrony or the abnormal
ventricular contraction induced by RV pacing is the most
important harmful factor in VVI pacing. Whether AAI or
DDD pacing is the optimal pacing mode in SSS is still not
clear. Both pacing modes preserve AV synchrony. Addi-
tionally, AAI pacing preserves the normal ventricular acti-
vation pattern; however, if AV block occurs, a re-operation
with implantation of a ventricular lead is needed. In con-
trast, DDD pacing protects against bradycardia if AV block
occurs, but the ventricular pacing causes an abnormal
ventricular activation pattern similar to that caused by VVI
pacing (3,4).
The primary aim of the present randomized study was to
compare the echocardiographic changes in LA size and LV
size and function during rate-adaptive AAI and DDD
pacing in patients with SSS and relatively normal AV
conduction.
METHODS
Protocol. The trial of AAIR versus DDDR pacing en-
rolled patients during the period from December 1994 to
March 1999, and follow-up was completed in March 2000.
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The primary end points were changes in LA size and LV
size and function during follow-up measured by M-mode
echocardiography. Secondary echocardiographic end points
were changes in LA volume and LV volume and left
ventricular ejection fraction (LVEF) measured by two-
dimensional echocardiography. Secondary clinical end
points were AF, thromboembolism, all-cause and cardio-
vascular mortality, and congestive HF. The trial included
consecutive patients with SSS, normal AV conduction, and
no bundle branch block referred to Skejby University
Hospital, Aarhus, Denmark, for their first pacemaker im-
plantation. The patients were asked to participate in the trial
if the inclusion criteria (symptomatic bradycardia 40
beats/min or symptomatic QRS pauses of more than 2 s)
and none of the exclusion criteria (Table 1) were met. A
normal AV conduction was arbitrarily defined as PQ inter-
val 220 ms for patients 70 years and PQ interval 260
ms for patients 70 years, as used in a prior study (the AAI
vs. VVI trial) (2,5). In a one-year period, patients were
furthermore enrolled at the neighboring Viborg County
Hospital.
After giving written informed consent, patients were
randomized to three arms: AAIR pacemaker, DDDR pace-
maker programmed with a conventional short rate-adaptive
AV delay (150 ms) (DDDR-s), and DDDR pacemaker
programmed with a fixed long AV delay (300 ms) (DDDR-
l).
Medical history and physical examination were done
before implantation. Echocardiography was done before,
and again within 24 h after, pacemaker implantation.
Follow-up visits were after three months, 12 months, and
then once a year. The follow-up visits included physical
examination, electrocardiogram (ECG) recordings, pace-
maker check-up, and echocardiography. Physical examina-
tion and echocardiography were done unblinded regarding
randomization and pacing mode. Echocardiography was
done blinded regarding prior echocardiographic examina-
tions.
Echocardiography. A Vingmed CFM 750 echocardio-
graph (Vingmed, Horten, Norway) with a 3.25 MHz
transducer was used for echocardiograms.
M-mode echocardiography was done to measure LA, LV
end-systolic (LVES) and end-diastolic (LVED) diameters,
and LVFS was calculated by the formula LVFS  (LVED
diameter  LVES diameter)/LVED diameter. M-mode
echocardiography was done in accordance with the recom-
mendations of the American Society of Echocardiography,
using the leading-edge methodology (6).
Two-dimensional echocardiography was used to measure
LA, LVED, and LVES volumes, allowing calculation of
the LVEF. Echocardiographic images were digitally stored
on optic disc and analyzed off-line using Echopac 6.0
(VINGMEDsound, Horten, Norway) software. The bi-
plane disc summation method was used for calculation of
ventricular volumes (7,8). Each LV volume was averaged
from three beats. If only one of the two apical standard
views could be obtained, the single plane disc summation
method was used. At follow-up of patients in the DDDR-s
group, echocardiographic parameters were initially obtained
in that pacing mode the patient presented—typically with
ventricular pacing. If ventricular pacing was present at that
Abbreviations and Acronyms
AAI(R)  single-chamber atrial pacemaker
(R indicates rate-adaptive pacing)
AF  atrial fibrillation
AV  atrioventricular
DDD  dual-chamber pacemaker
DDDR-l  dual-chamber pacemaker programmed with
a conventional fixed long AV delay of
300 ms
DDDR-s  dual-chamber pacemaker programmed with
a conventional short rate-adaptive AV delay
of 150 ms
HF  heart failure
LA  left atrial
LV  left ventricular
LVED  left ventricular end-diastolic
LVES  left ventricular end-systolic
LVEF  left ventricular ejection fraction
LVFS  left ventricular fractional shortening
NYHA  New York Heart Association
RV  right ventricular
SSS  sick sinus syndrome
VVI(R)  single-chamber ventricular pacemaker
(R indicates rate-adaptive pacing)
Table 1. Reasons for Exclusion in the AAIR Versus DDDR
Trial
Reasons for Exclusion
Number of
Patients
AV block grade 1,* 2, or 3 455
Chronic AF 98
Bundle branch block 43
AF 50% of time 22
AF with QRS rate 40 beats/min 22
Cerebral disease including dementia 17
Cardiac surgery planned 13
Follow-up not possible 11
Cancer 10
Pacing for HOCM 10
Age 18 yrs 9
Prior heart transplant 7
Major surgery, non-cardiac 5
Bradycardia and ventricular tachycardia 4
Wenckebach block 100 beats/min,
known before implantation
3
Carotid sinus syndrome 3
AF with RR intervals 3 s 2
Refusal 23
Other reasons 18
Total 775
*Grade 1 atrioventricular (AV) block was defined as: PQ interval 0.22 s in patients
70 years and PQ interval 0.26 s in patients 70 years.
AAIR  rate adaptive single chamber atrial pacemaker; AF  atrial fibrillation;
HOCM  hypertrophic obstructive cardiomyopathy; DDDR  rate adaptive dual
chamber pacemaker.
615JACC Vol. 42, No. 4, 2003 Nielsen et al.
August 20, 2003:614–23 AAIR vs. DDDR in Sick Sinus Syndrome
first echocardiogram, another echocardiogram was done 5
min after programming the pacemaker in AAI mode, same
rate (DDDR-s-AAI). Echocardiographic parameters at the
end of follow-up were defined as the measurements ob-
tained at the last follow-up of each patient, which could be
in the range from three months to five years. All echocar-
diograms were obtained and analyzed by one of three
experienced echocardiographers.
Variability. Thirty consecutive patients underwent inde-
pendent and separate M-mode echocardiographies by two
observers on the same day. Left atrial diameter and LVED
and LVES diameters were measured, and LVFS was cal-
culated. The bias (the mean intra-individual difference) was
low in all four parameters, whereas the limits of agreement
(the mean intra-individual difference  twice the SD of the
differences) were quite wide: 6.6 to 6.4 mm (LA diame-
ter), 9.5 to 8.7 mm (LVES diameter), 9.1 to 8.3 mm
(LVED diameter), 0.19 to 0.20 (LVFS) (9). Two-
dimensional echocardiography was performed and analyzed
by the same examiner in 10 consecutive patients, in whom
paired standard apical two- and four-chamber views were
available, on two separate days. For these two-dimensional
parameters, the bias was acceptable, and the limits of
agreement were quite wide: 6.9 to 11.7 ml (LVES
volume), 19.5 to 34.3 ml (LVED volume), 0.09 to 0.11
(LVEF).
During follow-up, good quality paired standard apical
two- and four-chamber views were available in only 50% to
60% of the patients. At the three-month follow-up, they
were available in 53% of the patients. In most of the
remaining patients, only one of the two apical views was
available and could be used to calculate the LV volumes.
Clinical end points. Atrial fibrillation was diagnosed only
by standard 12-lead ECG at planned follow-up visits.
Stroke was diagnosed when neurological symptoms of
presumably cerebral ischemic origin persisted for more than
24 h or if patients died within 24 h from an acute
cerebrovascular event. Peripheral embolus was diagnosed if
verified at embolectomy or necropsy. Cause of death was
obtained by interviewing the doctors who had care of the
patient and by review of hospital and necropsy reports.
Cardiovascular death included sudden death, death due to
congestive HF, arterial thromboembolism, or a pulmonary
embolus. Heart failure was classified according to New York
Heart Association (NYHA) criteria and quantitated by the
daily dose of diuretics.
Pacemaker telemetry data. Numbers of sensed and paced
events were retrieved from the pacemaker event counters at
every follow-up, and mean proportions of paced events in
the atrium and in the ventricle during the entire follow-up
period were calculated for each patient.
Pacemaker implantation. Standard rate-adaptive single-
chamber pacemakers and dual-chamber pacemakers (Car-
diac Pacemakers Inc. [St. Paul, Minnesota], Pacesetter [St.
Paul, Minnesota], Medtronic [Minneapolis, Minnesota])
were used, all fulfilling the study requirements for reporting
cumulative numbers of paced and sensed events for a
12-month period.
All atrial leads were implanted in the upper parts of the
right atrial wall. Among patients randomized to AAIR
pacing, 19 patients had unipolar leads, and 35 patients had
bipolar leads. Among patients randomized to DDDR pac-
ing, 37 patients had unipolar leads, and 86 patients had
bipolar leads in the right atrium. All patients randomized to
DDDR pacing had unipolar leads with passive fixation
implanted in the RV apex. Atrial fibrillation at the time of
pacemaker implantation was not a reason for implanting
another pacemaker rather than according to the randomized
mode.
During implantation, an atrial pacing test at 100 beats/
min was performed; 1:1 AV conduction was required for an
atrial pacemaker to be implanted. If Wenckebach block
occurred at a rate of 100 beats/min, the patient received a
DDDR pacemaker.
The rate response function was active in all but two
patients. Lower and upper rates were programmed individ-
ually. Mode-switch function was active in all patients
implanted with DDD pacemakers.
In patients randomized to DDDR-l pacing, the AV delay
was fixed at 300 ms. In four patients a shorter AV delay had
to be programmed to avoid induction of endless loop
tachycardia during initial pacemaker testing. In patients
randomized to DDDR-s pacing, the AV delay was 150 ms
and rate adaptive but even shorter if necessary to obtain
ventricular pacing with full capture.
Analysis. Power calculations were based on M-mode echo-
cardiographic data from the AAI versus VVI study (2).
With a statistical power of 80% and a 0.05 level of
significance, a total of 450 patients were to be included in
the study to detect a 10% difference between the AAIR
group and the DDDR group in LA diameter. No differ-
ences between the DDDR-s and the DDDR-l groups were
expected. However, inclusion was stopped after randomiza-
tion of 177 patients, because at that time a national
multi-center trial of AAIR versus DDDR pacing in patients
with SSS was initiated and started in Denmark (the Ran-
domized comparison of AAIR and DDDR pacing in 1,900
patients with SSS [DANPACE] trial) (10). Patients in-
cluded in the present study were not rolled over into the
DANPACE study.
The last patient included was to be followed up for at
least one year before data were analyzed, which was March
2000. Analysis was on an intention-to-treat basis. Contin-
uous variables were expressed as mean  SD. Treatment
groups were compared by the chi-square test for discrete
variables. Paired two-tailed t test was used for within-group
comparisons. One-way analysis of variance (ANOVA) was
used to compare continuous variables between groups.
Correlation analysis between proportion of pacing and
changes in echocardiographic parameters was done. Kaplan-
Meier survival curves were compared by log-rank test. A
Cox regression analysis was done to calculate the relative
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risk proportion of AF adjusted for brady-tachy syndrome. A
p value 0.05 (two-sided) was considered statistically sig-
nificant. No correction was done for multiple comparisons.
SPSS 10.0 was used for statistical analysis. The Institutional
Scientific Ethical Committee approved the study.
RESULTS
Patients. A total of 952 consecutive patients were im-
planted with their first pacemaker during the recruitment
period. Of these, 775 patients were excluded (Table 1), and
177 patients were included, 166 patients at Skejby Hospital
(20% of the population screened) and 11 patients at Viborg
County Hospital (11% of the population screened).
The 177 consecutive patients were randomized to AAIR
(n  54), DDDR-s (n  60), or DDDR-l (n  63) pacing.
Mean follow-up was 2.9  1.1 years (range, 6 days to 5.3
years) and similar in the three groups. No patients were lost
to follow-up. Baseline characteristics of the three groups
were similar (Table 2). The programmed minimum rate was
63  8 (range, 40 to 80) versus 60  4 (range, 50 to 70)
versus 61  5 (range, 50 to 70) beats/min, in the AAIR,
DDDR-s, and DDDR-l groups, respectively (p  0.04,
ANOVA). The programmed maximum rate was 120  8
(range, 100 to 130) versus 120  5 (range, 100 to 130)
versus 108  8 (range, 90 to 120), respectively (p  0.01,
ANOVA).
Pacing mode at implantation and at the end of follow-up
or death is shown in Figure 1. All patients randomized to
DDDR pacing were discharged from hospital with DDDR
pacing. Three patients randomized to AAIR pacing were
implanted with a DDDR pacemaker at primary implanta-
tion. In two patients the reason was Wenckebach block
below 100 beats/min at implantation; in one patient it was
impossible to obtain an acceptable atrial sensing value
during AF, and a ventricular lead was implanted for safety
reasons.
During follow-up, three patients randomized to AAIR
pacing had ventricular leads implanted because of develop-
Table 2. Baseline Characteristics at the Time of Pacemaker Implantation
Patients’ Characteristics AAIR DDDR-s DDDR-l
Number of patients 54 60 63
Age (yrs) 74  9 74  9 74  9
Female (n) 31 34 39
Mean follow-up (yrs) 3.1  1.3 2.8  1.5 2.8  1.4
Blood pressure (mm Hg)
Systolic 145  24 139  22 144  22
Diastolic 80  13 75  12 80  10
Arrhythmia indicating pacemaker treatment
Sinus bradycardia (n) 8 5 11
Sino-atrial block (n) 19 17 16
BTS (n) 27 38 36
Symptoms indicating pacemaker treatment
Syncope (n) 19 26 24
Dizzy spells (n) 34 32 34
Heart failure (n) 1 2 5
CAD (n) 21 25 22
DM (n) 6 6 7
NYHA class (n)
I 32 38 46
II 18 22 14
III 2 3
IV 1
Electrocardiographic parameters
PQ interval (ms) 186  27 183  28 184  27
Wenckebach block point (n)*
100/min 2 5 3
100/min 50 52 57
Medication (n)
Beta-blocker 4 5 7
Ca-blocker 14 7 11
Digoxin 11 9 11
Sotalol 7 8 10
Aspirin 35 40 36
Warfarin 5 5 11
Continuous data are mean  SD, other variables reported as number of patients. *The Wenckebach block point could not be
tested in patients having atrial fibrillation during implantation.
AAIR  rate adaptive single chamber atrial pacemaker; BTS  brady-tachy syndrome; CAD  coronary artery disease;
DDDR-l  dual-chamber pacemaker programmed with a conventional fixed long AV delay of 250 ms; DDDR-s 
dual-chamber pacemaker programmed with a conventional short rate-adaptive AV delay of 110 to 150 ms; DM  diabetes;
NYHA  New York Heart Association.
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ment of high-degree AV block (1.9% per year). The
symptoms associated with AV block were dizzy spells in two
patients and syncope in one patient. The PQ interval at
baseline for each of these three patients was 200 ms, 180 ms,
and 160 ms, respectively. In these patients, AAIR mode was
changed to DDDR-l mode. Four patients in the DDDR
group had their pacing mode changed to VVI pacing
because of development of persistent AF. One patient was
changed from DDDR mode to AAIR mode after 13
months because of malfunction of the ventricular lead.
Re-operation was not done in this patient, because of lung
cancer.
Echocardiographic changes. M-MODE. The within-group
comparisons of the M-mode parameters obtained before
pacemaker implantation and at the end of follow-up are
listed in Table 3. The within-group differences (delta
values) did not differ between groups for any of the
parameters.
LA diameter. Mean LA diameter at implantation and
during follow-up is shown in Figure 2. Before pacemaker
implantation there was no difference in LA diameter be-
tween groups (p  0.98, ANOVA), nor was there any
difference between groups at last follow-up (p  0.23,
ANOVA). Graphically, LA diameter seemed to increase
during follow-up, especially in the DDDR-s group (Fig. 2).
Statistically, LA diameter increased significantly during
follow-up in the two DDDR groups and in the DDDR-s-
AAI group, but not in the AAIR group (Table 3).
LV diameters and LVFS. Left ventricular diameters and
LVFS did not differ between groups at baseline or at last
follow-up. A significant increase in LVES diameters in both
the DDDR-s group and the DDDR-l group was observed
during follow-up (Table 3). In the DDDR-l group, a
significant increase was seen also in the LVED diameter. In
the DDDR-s-AAI group, both LVES and LVED diame-
ters increased significantly during follow-up. In the
DDDR-s group and in the DDDR-s-AAI group, LVFS
decreased significantly from baseline to last follow-up.
The changes observed in the LA and LV diameters
during follow-up were similar after exclusion of the patients
who had AF at echocardiography before pacemaker implan-
tation or at one or more of the follow-up visits (Table 3).
Two-dimensional parameters. The within-group com-
parisons of the two-dimensional echocardiographic param-
eters obtained before pacemaker implantation and at the
end of follow-up are listed in Table 4. The within-group
differences did not differ between groups for any of the
parameters. Left atrial, LVED, and LVES volumes did not
differ between groups at baseline or at last follow-up, nor
did LVEF differ between groups at baseline or at last
follow-up.
Comparing LA volume before pacemaker implantation
and at last follow-up within groups, no significant changes
were found in the three randomization groups nor in the
DDDR-s-AAI group (Table 4).
In the AAIR group and in the DDDR-s group, LVES
volume increased, and LVEF decreased significantly during
follow-up (Table 4).
Pacemaker telemetry data. Mean proportion of pacing
during follow-up was, in the atrium: 69% in the AAIR
Figure 1. Pacing mode at implantation and at the end of follow-up or death. VVI  single chamber ventricular pacemaker; other abbreviations as in Tables
1 and 2.
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group, 57% in the DDDR-s group, and 67% in the
DDDR-l group (p  0.08, ANOVA); in the ventricle: 90%
in the DDDR-s group and 17% in the DDDR-l group (p
0.001, ANOVA). Correlation between mean proportion of
pacing in the ventricle during follow-up and the relative
changes in LA diameter, LVES and LVED diameters, and
LVFS from before implantation until end of follow-up was
done for the DDDR-s and the DDDR-l groups. Correla-
tion between mean proportion of pacing in the atrium
during follow-up and the relative change in LA diameter
was done for all three randomization groups. No significant
linear correlation was observed.
Clinical end points. During follow-up, AF at one or more
ambulatory visits was significantly less common in the
AAIR group, 7.4% (n  4) versus 23.3% (n  14) in the
DDDR-s group versus 17.5% (n  11) in the DDDR-l
group (p  0.03, log-rank test). Kaplan-Meier plots of the
proportions of patients in the three groups without AF
during follow-up are shown in Figure 3. Brady-tachy
syndrome at pacemaker implantation was strongly associ-
ated with AF during follow-up (relative risk 3.3 [95%
confidence interval 1.3 to 8.1], p  0.01). The risk of
developing AF in the AAIR group compared with the
DDDR-s group was still significantly decreased after ad-
justing for brady-tachy syndrome (relative risk 0.27 [95%
confidence interval 0.09 to 0.83], p  0.02). Programmed
lower rate was not different among patients with and
without AF during follow-up (61.3 beats/min vs. 61.7
beats/min, p  0.74).
A total of 16 strokes occurred during follow-up in 14Ta
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Figure 2. Mean left atrial diameter from M-mode echocardiographic
measurements at implantation and during follow-up. Pre  the day before
pacemaker implantation; 1 day  the day after pacemaker implantation.
Numbers below x-axis indicate numbers of patients who had M-mode
echocardiography at each follow-up in each group. Solid diamonds 
AAIR; solid squares  DDDR-s; solid triangles  DDDR-l; stars 
DDDR-s-AAI. Abbreviations as in Tables 1 and 2.
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patients, 3 patients from the AAIR group (5.6%), 7 patients
from the DDDR-s group (11.7%), and 4 patients from the
DDDR-l group (6.3%) (p 0.32, log-rank test). Peripheral
emboli were not observed.
A total of 37 patients died during follow-up, nine patients
(16.7%) in the AAIR group, 14 patients (23.3%) in the
DDDR-s group, and 14 patients (22.2%) in the DDDR-l
group (p  0.51, log-rank test). Annual rate of mortality
was 5.4%, 8.4%, and 8.0%, respectively. Cardiovascular
mortality was 7.4% versus 11.7% versus 14.3% (p  0.43,
log-rank test).
Before pacemaker implantation, there were no differences
in NYHA functional class or consumption of diuretics
between the AAIR, DDDR-s, and DDDR-l groups. Dur-
ing follow-up, 31% versus 30% versus 46% of patients in the
three groups increased at least one NYHA class (p  0.17,
chi-square test), and increase in consumption of diuretics
was observed in 28% versus 32% versus 21% of patients in
the three groups (p  0.34, chi-square test).
DISCUSSION
Our study is the first randomized trial comparing AAIR and
DDDR pacing in patients with SSS and normal AV
conduction. The study indicates that long-term DDDR
pacing induces LA dilation and, in the case of a high
proportion of RV pacing, also reduces LV function. Fur-
thermore, AF is significantly less common during AAIR
pacing. These findings support AAIR pacing as the pre-
ferred pacing mode in this group of patients.
In the present trial, DDDR pacing with 90% RV pacing
induced changes identical to the changes observed in the
VVI group in the AAI versus VVI trial (1,2), with a
decrease in LVFS and an increase in LA dilation, and
DDDR-l pacing (with a mean 17% of RV pacing) caused
only an increase in LA diameter, with no change in LVFS.
These findings support that a high proportion of RV pacing
causes a decrease in LV function. This is in accordance with
recent findings from the randomized MOST (The Mode
Selection Trial in Sinus-Node Dysfunction) (11) trial,
where increasing proportions of pacing in the RV was
associated with increase in the risk of hospitalization for HF
(12).
The persistent LA dilation and LVFS decrease in the
DDDR-s group after programming to AAI mode (DDDR-
s-AAI) indicate that the effects of long-term RV pacing on
LV function and LA size also persist after cessation of
pacing. The echocardiographic study in AAI mode was,
however, done only 5 min after programming to AAI mode,
and it is not known whether the LA dilation and LVFS
decrease would revert, given a longer period without RV
pacing. In dogs, long-term AV synchronous LV pacing has
been reported to induce ventricular remodeling with asym-
metrical hypertrophy of the LV wall, thinning of the earliest
activated free wall, and thickening of the late-activated
septum (13,14). The present results do not answer whetherTa
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a similar remodeling occurs during long-term RV pacing in
humans.
In the present study, LA diameter increased significantly
in both DDDR groups but not in the AAIR group. The LA
dilation is possibly caused by the abnormal activation
sequence and mechanical contraction pattern of the ventri-
cles induced by RV pacing (3,4,15,16) associated with a
decrease in the LV systolic (3,4) and diastolic function (15)
and an increase in the right atrial pressure and the pulmo-
nary capillary wedge pressure (3,17,18). The LA dilation
was more marked in the DDDR-s group with 90% RV
pacing than in the DDDR-l group with 17% RV pacing,
supporting an association between these two parameters.
The non-significant increase in LA diameter observed in
the AAIR group could represent a feature in the natural
evolution of the SSS and/or be related to increasing age
(19). In the present study, the ventricular lead was im-
planted in the RV apex. Using RV septal pacing might have
influenced the present results (20,21).
Patients with DDDR pacemakers were programmed with
either a short rate-adaptive AV delay or a long fixed AV
delay. Optimizing the AV delay individually might have
influenced the present results (22). However, the study was
designed to evaluate effects of different proportions of
ventricular pacing rather than DDDR pacing with an
optimized AV delay. Despite programming of a fixed long
AV interval, pacing in the RV was reduced to a mean of
only 17%. The explanation of this finding probably is RV
fusion beats, RV pacing during AF, and RV pacing during
different forms of pacemaker tachycardias, as previously
documented (22).
When the present study was designed in the early 1990s,
two-dimensional echocardiography was expected to yield
more precise information of the changes over time in LA
and LV dimensions than M-mode echocardiography. The
results of our two-dimensional echocardiographic studies do
not support the findings done by M-mode echocardiogra-
phy. The changes observed in left chamber volumes and
LVEF during follow-up were all small in size and within
the 95% confidence intervals of repeated two-dimensional
echocardiographic studies (23,24). Measuring the LA vol-
ume by two-dimensional echocardiography has never found
any place in clinical or scientific echocardiography. Further-
more, in contrast with LA diameter measured by M-mode
Figure 3. Kaplan-Meier plots of freedom from atrial fibrillation during follow-up. Atrial fibrillation was diagnosed only by standard 12-lead
electrocardiogram at planned follow-up visits, not in-between these visits. AAIR  single lead atrial pacing; DDDR-l  dual-chamber pacing with the
pacemaker programmed with a fixed atrioventricular (AV) delay of 300 ms; DDDR-s  dual-chamber pacing with the pacemaker programmed with a
rate-adaptive AV delay 150 ms and ventricular capture.
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echocardiography (25), LA volume has never been found
predictive of later cardiovascular events.
The correlations between mean proportion of RV pacing
and the changes in LA and LV diameters during follow-up
and the correlations between mean proportion of pacing in
the atrium and changes in LA diameter were all non-
significant, most likely because of the insufficient accuracy of
echocardiography (23,26).
In the present trial, AF was significantly more common
in the two DDDR groups, indicating that RV pacing may
promote AF, most likely because it causes LA dilation.
Similar changes in the echocardiographic parameters were
observed after excluding patients who had AF at their
echocardiographic examinations, indicating that AF was not
the cause of the echocardiographic changes observed. We
observed no differences in occurrence of thromboembolism,
congestive HF, or death between pacing modes during
follow-up, indicating that AAIR and DDDR pacing is
similar regarding these outcomes. The limited sample size
must, however, be kept in mind when interpreting these
data. The incidence of high-degree AV block in the AAIR
group was comparable to the annual rate of 1.7% observed
in a recent retrospective study of 399 consecutive patients
treated with AAI(R) pacing in our institution (27).
At present time, AAI(R) pacing mode seems to be the
optimal treatment for isolated SSS. In the future, new mode
switching abilities between DDD and AAI pacing may
enable AAI pacing the majority of the time and, in addition,
protect the patients from severe bradycardia due to AV
block. The currently ongoing DANPACE trial (10) is
expected to answer whether the risks associated with
AAI(R) pacing and AV block are less than the risks
associated with RV pacing in DDD(R) mode.
Study limitations. In our previous study, the differences
between pacing modes increased markedly during long-
term follow-up (2,28). In the present study the mean
follow-up was just below three years. The present results
cannot be extrapolated beyond this period after pacemaker
implantation. Our study was initially designed to include
450 patients, but inclusion was stopped prematurely after
randomizing 177 patients, reducing the statistical power.
The echocardiographic measurements were done un-
blinded with regard to pacing mode and randomization
group. Furthermore, at the ambulatory follow-up visits,
echocardiography was done in the AAI mode 5 min after
echocardiography in the DDD mode when ventricular
pacing had been present in that mode. These factors may
have introduced an observer bias. However, results from
prior echocardiographic studies of any particular patient in
the study were not known at the time of later echocardio-
graphic studies or analyses of echocardiographic data in that
patient.
For evaluating the proportions of pacing and sensing in
the chambers, we had to rely on telemetered data. Far-field
over-sensing of R waves in the atrium and of T waves in the
ventricle as well as under-sensing of small atrial electro-
grams during AF may have influenced these data. To reduce
these sense problems, bipolar atrial leads were used in the
majority of patients. It is unlikely that the reliability of
telemetered data should be different between randomization
groups.
Conclusions. Our study is the first randomized trial com-
paring AAIR and DDDR pacing in patients with SSS and
normal AV conduction. The study indicates that long-term
DDDR pacing induces LA dilation and, in the case of a
high proportion of LV pacing, also reduces LV function.
Furthermore, AF is significantly less common during AAIR
pacing. These findings support AAIR pacing as the pre-
ferred pacing mode in this group of patients.
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